10x Genomics Inc. Class A Common Stock (0A88)
LSE
74.33
-3.35 (-4.31%)
Closed
Oct 8, 2026
Day's Range
70.9076.00
52 wk Range
11.17102.81
Financial Statements - 0A88 - 10x Genomics Inc. Class A Common Stock
Revenue
1.05M▲ 114.0%
Net Income
-13.39M▼ 546.0%Net Margin -1272.0%
EBITDA
-8.40M▼ 548.7%
Free Cash Flow
-7.21M▼ 393.2%
Income Statement
| Period Ending | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2019-03-31 |
|---|---|---|---|---|
| Sales | 1.05M | 492.12K | 0 | 125K |
| Cost of Goods | 1.02M | 397.59K | - | - |
| Gross Profit | 24.32K | 94.53K | - | - |
 Operating Expense | - | - | - | - |
| Operating Income | -11.68M | -1.34M | -1.56M | -1.75M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | -1.50M | - | -4.15M | -131.10K |
| Pre Tax Income | -13.48M | -2.07M | -6.39M | -1.88M |
| Income Tax | -90.36K | - | - | - |
| Net Income | -13.39M | -2.07M | -6.39M | -1.88M |
| EPS Basic | -4.259991 | -0.299999 | -2.399995 | -1.199998 |
| EPS Diluted | -4.259991 | -0.299999 | -2.399995 | -1.199998 |
| Basic Shares Outstanding | 3.15M | 6.87M | 2.40M | 1.80M |
| Diluted Shares Outstanding | 3.15M | 6.87M | 2.40M | 1.80M |
| Ebit | - | - | - | - |
| Ebitda | -8.40M | -1.29M | -1.55M | -1.62M |
| Net Income Continuous Operations | -13.39M | -2.07M | -6.39M | -1.88M |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
